Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Qu

Showing results (81-90 of 488) with videos related to

Pageof 49
Sort By:
The AAPS Journal|October 17, 2022
Identification of Potential Megalin/Cubilin Substrates Using Extensive Proteomics Quantification from Kidney Megalin-Knockdown MiceBei Zhao, Chengjian Tu, Shichen Shen, et al.
Oncology|September 3, 2005
Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell linesJia-Lin Yang, Xian-Jun Qu, Pamela J Russell, et al.
Angewandte Chemie (International Ed. in English)|March 4, 2008
A photoinducible 1,3-dipolar cycloaddition reaction for rapid, selective modification of tetrazole-containing proteinsWenjiao Song, Yizhong Wang, Jun Qu, et al.
Cancer Letters|June 1, 2005
Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell linesJia-Lin Yang, Xian-Jun Qu, Pamela J Russell, et al.
Cancer Investigation|January 31, 2018
Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin PathwaysZhi-Yu Song, Feng Wang, Shu-Xiang Cui, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 28, 2015
Knockdown of type I insulin-like growth factor receptor inhibits human colorectal cancer cell growth and downstream PI3K/Akt, WNT/β-catenin signal pathwaysQian-yun Zhang, Lu Wang, Zhi-yu Song, et al.
RSC Advances|March 6, 2023
Organic-modified ZnS nanoparticles as a high-performance lubricant additiveChanaka Kumara, Beth Armstrong, Inwoong Lyo, et al.
Journal of Proteome Research|October 31, 2023
Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces Cancer Cell Death via Metabolic Remodeling and Activation of the Extrinsic Apoptosis PathwaySailee Rasam, Qingxiang Lin, Shichen Shen, et al.
Anatomical Record (Hoboken, N.J. : 2007)|January 14, 2020
Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axisXiaoqiu Yang, Nana Xin, Hai-Jun Qu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 10, 2015
{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) inhibited human hepatocellular carcinoma growth through upregulation of Sirtuin-3 (SIRT3)Ye Li, Wenjing Wang, Xiaoxue Xu, et al.
Pageof 49

Showing results (81-90 of 488) with videos related to

Sort By:
Pageof 49
The AAPS Journal|October 17, 2022
Identification of Potential Megalin/Cubilin Substrates Using Extensive Proteomics Quantification from Kidney Megalin-Knockdown MiceBei Zhao, Chengjian Tu, Shichen Shen, et al.
Oncology|September 3, 2005
Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell linesJia-Lin Yang, Xian-Jun Qu, Pamela J Russell, et al.
Angewandte Chemie (International Ed. in English)|March 4, 2008
A photoinducible 1,3-dipolar cycloaddition reaction for rapid, selective modification of tetrazole-containing proteinsWenjiao Song, Yizhong Wang, Jun Qu, et al.
Cancer Letters|June 1, 2005
Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell linesJia-Lin Yang, Xian-Jun Qu, Pamela J Russell, et al.
Cancer Investigation|January 31, 2018
Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin PathwaysZhi-Yu Song, Feng Wang, Shu-Xiang Cui, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 28, 2015
Knockdown of type I insulin-like growth factor receptor inhibits human colorectal cancer cell growth and downstream PI3K/Akt, WNT/β-catenin signal pathwaysQian-yun Zhang, Lu Wang, Zhi-yu Song, et al.
RSC Advances|March 6, 2023
Organic-modified ZnS nanoparticles as a high-performance lubricant additiveChanaka Kumara, Beth Armstrong, Inwoong Lyo, et al.
Journal of Proteome Research|October 31, 2023
Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces Cancer Cell Death via Metabolic Remodeling and Activation of the Extrinsic Apoptosis PathwaySailee Rasam, Qingxiang Lin, Shichen Shen, et al.
Anatomical Record (Hoboken, N.J. : 2007)|January 14, 2020
Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axisXiaoqiu Yang, Nana Xin, Hai-Jun Qu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 10, 2015
{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) inhibited human hepatocellular carcinoma growth through upregulation of Sirtuin-3 (SIRT3)Ye Li, Wenjing Wang, Xiaoxue Xu, et al.
Pageof 49